The trademark application AMI AbbVie Medical Institute was filed by AbbVie Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 9, 2022, and it was registered by office on August 16, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 41 with Education services, namely conducting classes, workshops, training seminars, and discussion forums in the fields of breast augmentation, facial aesthetics and implants, medical devices and general cosmetic surgery.